This program provides updates on the evolving landscape of oncolytic viruses and summarizes the rationale for their use in challenging treatment settings. Faculty review the latest clinical evidence and discuss the potential positioning of emerging oncolytic viruses within existing treatment paradigms for patients with advanced melanoma.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/hematology-oncology/20240418/melanoma-oncolytic-immunotherapy/overview
- Start Date: 2024-05-29 05:00:00
- End Date: 2024-05-29 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: Replimune - Amount: 49993.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest